Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Hematological Oncology|June 9, 2021
Molecular classification of aggressive lymphomas-past, present, futureKirsty Wienand, Björn Chapuy
Journal of Cancer Research and Clinical Oncology|September 2, 2016
Cancer testis antigen MAGE C1 can be used to monitor levels of circulating malignant stem cells in the peripheral blood of multiple myeloma patientsKaren Shires, Kirsty Wienand
Plos One|March 21, 2015
The use of MAGE C1 and flow cytometry to determine the malignant cell type in multiple myelomaKirsty Wienand, Karen Shires
Cancer Journal (Sudbury, Mass.)|August 1, 2020
Molecular Classification of Large B-Cell Non-Hodgkin LymphomaKamil Bojarczuk, Kirsty Wienand, Bjoern Chapuy
Blood Research|August 31, 2021
The expression of multiple cancer/testis antigens can potentially be used to detect circulating disease and clonal evolution in the peripheral blood of multiple myeloma patientsKaren Shires, Teagan Van Wyk, Kirsty Wienand
Biorxiv : the Preprint Server for Biology|March 11, 2024
CTAT-LR-fusion: accurate fusion transcript identification from long and short read isoform sequencing at bulk or single cell resolutionQian Qin, Victoria Popic, Houlin Yu, et al.
Blood|October 17, 2018
Targeted inhibition of PI3Kα/δ is synergistic with BCL-2 blockade in genetically defined subtypes of DLBCLKamil Bojarczuk, Kirsty Wienand, Jeremy A Ryan, et al.
Haematologica|September 1, 2019
CXCR4 upregulation is an indicator of sensitivity to B-cell receptor/PI3K blockade and a potential resistance mechanism in B-cell receptor-dependent diffuse large B-cell lymphomasLinfeng Chen, Jing Ouyang, Kirsty Wienand, et al.
Genome Research|March 14, 2025
Accurate fusion transcript identification from long- and short-read isoform sequencing at bulk or single-cell resolutionQian Qin, Victoria Popic, Kirsty Wienand, et al.
Blood|December 16, 2024
DLBclass: a probabilistic molecular classifier to guide clinical investigation and practice in diffuse large B-cell lymphomaBjörn Chapuy, Timothy Wood, Chip Stewart, et al.
Pageof 2